Luigi Adamo is a Cardiology physician affiliated with Johns Hopkins University. OpenAlex indexes 149 publications with 3,121 citations (h-index 25).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
600 N Wolfe St
Baltimore, MD 212870005
Telephone
410-955-5000Provider last certified this registry record 30 Mar 2023.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20251 payment
- Novo Nordisk US Research & Development, Inc.Program year20241 payment
- Kiniksa Pharmaceuticals International, plcProgram year20242 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
77.9%Beta blocker26.7%Metoprolol Succinate53%Carvedilol34%Bisoprolol Fumarate13%Part D<11 patientsAldosterone antagonist (MRA)15.7%Spironolactone72%Eplerenone28%Part D<11 patients+ 4 more classes in this area
Metabolism & gastrointestinal
17.3%SGLT2 inhibitor17.3%Jardiance100%Part D≥22 patientsBlood & clotting
4.8%Factor Xa inhibitor4.8%Eliquis100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
3 NIH research awards on record, funded 2020–2026 per NIH RePORTER. The latest:
- B cell-mediated antigen presentation drives sex-specific differences in the activation of the cardio-splenic axis of chronic heart failure
Johns Hopkins University
FY2026$763,036R01HL178615 - Myocardial-associated B lymphocytes and inflammatory injury
Johns Hopkins University
FY2025$524,689R01HL160716 - Myocardial-associated B lymphocytes and inflammatory injury
Johns Hopkins University
FY2024$461,927R01HL160716
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Roger Blumenthal, MD
Johns Hopkins University
Erin Michos, MD
Johns Hopkins University
Morgan Grams, MD
Johns Hopkins University
Mario Eisenberger, MD
Johns Hopkins University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”